Marc H. Scheetz

6.8k total citations
199 papers, 4.4k citations indexed

About

Marc H. Scheetz is a scholar working on Pharmacology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Marc H. Scheetz has authored 199 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Pharmacology, 75 papers in Epidemiology and 70 papers in Infectious Diseases. Recurrent topics in Marc H. Scheetz's work include Antibiotics Pharmacokinetics and Efficacy (102 papers), Antimicrobial Resistance in Staphylococcus (58 papers) and Antibiotic Resistance in Bacteria (47 papers). Marc H. Scheetz is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (102 papers), Antimicrobial Resistance in Staphylococcus (58 papers) and Antibiotic Resistance in Bacteria (47 papers). Marc H. Scheetz collaborates with scholars based in United States, Australia and Greece. Marc H. Scheetz's co-authors include Michael Postelnick, Nathaniel J. Rhodes, Chao Qi, Michael Malczynski, Milena M. McLaughlin, Sean N. Avedissian, Gwendolyn Pais, Jiajun Liu, Thomas P. Lodise and Teresa Zembower and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Marc H. Scheetz

187 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marc H. Scheetz United States	40	1.8k	1.6k	1.4k	1.3k	788	199	4.4k
Dafna Yahav Israel	41	1.1k 0.6×	1.8k 1.1×	1.6k 1.1×	1.3k 1.0×	645 0.8×	207	5.5k
Sheryl Zelenitsky Canada	31	2.1k 1.2×	1.3k 0.8×	1.0k 0.7×	2.0k 1.5×	738 0.9×	80	4.3k
Michael Neely United States	38	3.4k 1.9×	2.4k 1.5×	2.7k 1.9×	962 0.7×	633 0.8×	178	6.7k
Manjunath P. Pai United States	37	2.7k 1.5×	1.9k 1.2×	3.1k 2.2×	681 0.5×	653 0.8×	176	6.6k
Francesco Giuseppe De Rosa Italy	36	1.2k 0.7×	2.0k 1.3×	1.7k 1.2×	1.6k 1.2×	808 1.0×	285	5.7k
Annie Wong‐Beringer United States	31	1.5k 0.8×	1.2k 0.8×	2.4k 1.7×	783 0.6×	442 0.6×	86	4.3k
David E. Nix United States	39	2.7k 1.5×	2.7k 1.8×	1.4k 1.0×	1.4k 1.1×	483 0.6×	140	5.8k
Christian Joukhadar Austria	40	1.9k 1.1×	1.3k 0.9×	1.0k 0.7×	865 0.6×	223 0.3×	100	4.4k
David S. Burgess United States	34	1.4k 0.8×	1.1k 0.7×	744 0.5×	1.2k 0.9×	481 0.6×	119	3.4k
Kerry L. LaPlante United States	37	1.0k 0.6×	1.6k 1.0×	2.1k 1.5×	904 0.7×	657 0.8×	144	4.7k

Countries citing papers authored by Marc H. Scheetz

Since Specialization

Citations

This map shows the geographic impact of Marc H. Scheetz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc H. Scheetz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc H. Scheetz more than expected).

Fields of papers citing papers by Marc H. Scheetz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc H. Scheetz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc H. Scheetz. The network helps show where Marc H. Scheetz may publish in the future.

Co-authorship network of co-authors of Marc H. Scheetz

This figure shows the co-authorship network connecting the top 25 collaborators of Marc H. Scheetz. A scholar is included among the top collaborators of Marc H. Scheetz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc H. Scheetz. Marc H. Scheetz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chang, Jack, Gwendolyn Pais, Erin F. Barreto, et al.. (2024). Past, present, and future biomarkers of kidney function and injury: The relationship with antibiotics. International Journal of Antimicrobial Agents. 64(5). 107332–107332. 2 indexed citations

Schwartz, Zachary, et al.. (2024). Meta-analysis on safety of standard vs. prolonged infusion of beta-lactams. International Journal of Antimicrobial Agents. 64(4). 107309–107309. 2 indexed citations

Leino, Abbie D., Ruiting Li, Kevin J. Downes, et al.. (2023). Bioanalysis of Six Antibiotics from Volumetric Microsamples: A New Tool for Precision Dosing in Critically ill Children. Bioanalysis. 16(1). 19–31. 1 indexed citations

Fletcher, Courtney V., Anthony T. Podany, Shetty Ravi Dyavar, et al.. (2023). A novel 4-cell in-vitro blood-brain barrier model and its characterization by confocal microscopy and TEER measurement. Journal of Neuroscience Methods. 392. 109867–109867. 5 indexed citations

Scheetz, Marc H., Gwendolyn Pais, Thomas P. Lodise, et al.. (2021). Of Rats and Men: a Translational Model To Understand Vancomycin Pharmacokinetic/Toxicodynamic Relationships. Antimicrobial Agents and Chemotherapy. 65(10). e0106021–e0106021. 10 indexed citations

O’Donnell, J. Nicholas, Nathaniel J. Rhodes, Teresa Zembower, et al.. (2021). Impact of early antimicrobial stewardship intervention in patients with positive blood cultures: results from a randomized comparative study. International Journal of Antimicrobial Agents. 59(2). 106490–106490. 3 indexed citations

Liu, Jiajun, Michael Neely, Jeffrey Lipman, et al.. (2020). Development of Population and Bayesian Models for Applied Use in Patients Receiving Cefepime. Clinical Pharmacokinetics. 59(8). 1027–1036. 9 indexed citations

Liu, Jiajun, Gwendolyn Pais, Sean N. Avedissian, et al.. (2020). Evaluation of Dose-Fractionated Polymyxin B on Acute Kidney Injury Using a Translational In Vivo Rat Model. Antimicrobial Agents and Chemotherapy. 64(5). 6 indexed citations

Avedissian, Sean N., Gwendolyn Pais, Jiajun Liu, et al.. (2020). The Pharmacodynamic-Toxicodynamic Relationship of AUC and C _max in Vancomycin-Induced Kidney Injury in an Animal Model. Antimicrobial Agents and Chemotherapy. 65(3). 15 indexed citations

10.

Morrisette, Taylor, Thomas P. Lodise, Marc H. Scheetz, et al.. (2020). The Pharmacokinetic and Pharmacodynamic Properties of Hydroxychloroquine and Dose Selection for COVID-19: Putting the Cart Before the Horse. Infectious Diseases and Therapy. 9(3). 561–572. 19 indexed citations

11.

Avedissian, Sean N., Gwendolyn Pais, Jiajun Liu, Nathaniel J. Rhodes, & Marc H. Scheetz. (2019). Piperacillin-Tazobactam Added to Vancomycin Increases Risk for Acute Kidney Injury: Fact or Fiction?. Clinical Infectious Diseases. 71(2). 426–432. 36 indexed citations

12.

Pais, Gwendolyn, Jiajun Liu, Sean N. Avedissian, et al.. (2019). Lack of synergistic nephrotoxicity between vancomycin and piperacillin/tazobactam in a rat model and a confirmatory cellular model. Journal of Antimicrobial Chemotherapy. 75(5). 1228–1236. 38 indexed citations

13.

McLaughlin, Milena M., et al.. (2018). Effect of elevated imipenem/cilastatin minimum inhibitory concentrations on patient outcomes in Gram-negative bloodstream infections. Journal of Global Antimicrobial Resistance. 13. 261–263. 2 indexed citations

14.

Bidell, Monique R., Manjunath P. Pai, Marc H. Scheetz, et al.. (2017). Relationship between day 1 and day 2 Vancomycin area under the curve values and emergence of heterogeneous Vancomycin-intermediate Staphylococcus aureus (hVISA) by Etest® macromethod among patients with MRSA bloodstream infections: a pilot study. BMC Infectious Diseases. 17(1). 534–534. 7 indexed citations

15.

Esterly, John S., Jamie L. Wagner, Milena M. McLaughlin, et al.. (2012). Evaluation of Clinical Outcomes in Patients with Bloodstream Infections Due to Gram-Negative Bacteria According to Carbapenem MIC Stratification. Antimicrobial Agents and Chemotherapy. 56(9). 4885–4890. 66 indexed citations

16.

Griffith, Matthew, Alan E. Gross, Sarah H. Sutton, et al.. (2012). The Impact of Anti-infective Drug Shortages on Hospitals in the United States: Trends and Causes. Clinical Infectious Diseases. 54(5). 684–691. 50 indexed citations

17.

Esterly, John S., et al.. (2010). Evaluation of Hepatotoxicity with Off-Label Oral-Treatment Doses of Voriconazole for Invasive Fungal Infections. Antimicrobial Agents and Chemotherapy. 55(1). 184–189. 13 indexed citations

18.

Scheetz, Marc H., et al.. (2008). Effect of Differences in MIC Values on Clinical Outcomes in Patients with Bloodstream Infections Caused by Gram-Negative Organisms Treated with Levofloxacin. Antimicrobial Agents and Chemotherapy. 53(3). 1074–1079. 32 indexed citations

19.

Scarsi, Kimberly K., Joe Feinglass, Marc H. Scheetz, et al.. (2006). Impact of Inactive Empiric Antimicrobial Therapy on Inpatient Mortality and Length of Stay. Antimicrobial Agents and Chemotherapy. 50(10). 3355–3360. 40 indexed citations

20.

Scheetz, Marc H.. (2005). Real-Time, Unit-Specific Antimicrobial Susceptibility Identifies Significant Differences among Gram-Negative Bacteria. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact